Collegium Pharmaceutical, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	193.5M	205.4M	209.4M	188.0M	177.8M	181.9M	159.3M	145.3M
Cost of Goods Sold	76.3M	77.1M	80.2M	79.6M	80.4M	83.7M	62.5M	54.5M
Gross Profit	117.2M	128.4M	129.2M	108.4M	97.3M	98.3M	96.8M	90.8M
R&D Expenses	0	0	0	0	0	0	0	0
Operating Expenses	85.3M	69.2M	65.6M	73.3M	75.6M	60.2M	62.0M	43.3M
Operating Income	32.0M	59.2M	63.6M	35.1M	21.7M	38.1M	34.8M	47.5M
Other Income / Gains	-13.2M	-30.2M	-20.2M	-18.1M	-18.6M	-20.8M	-19.3M	-18.4M
Net Income	14.5M	17.0M	31.5M	12.0M	2.4M	12.5M	9.3M	19.6M
EPS (Diluted)	0.45	0.54	1.00	0.38	0.076	0.39	0.33	0.60
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.606	0.625	0.617	0.577	0.548	0.54	0.608	0.625
General And Administrative Expenses	0	0	0	0	0	0	0	0
Selling And Marketing Expenses	0	0	0	0	0	0	0	0
Selling General And Administrative Expenses	0	67.6M	65.6M	73.6M	76.4M	63.1M	62.0M	43.3M
Other Expenses	85.3M	1.5M	0	-358K	-786K	-2.9M	0	0
Cost And Expenses	161.6M	146.2M	145.7M	152.9M	156.1M	143.8M	124.5M	97.8M
Interest Income	3.7M	3.6M	3.1M	2.4M	2.2M	1.8M	3.3M	4.4M
Interest Expense	15.9M	104.8M	21.8M	20.5M	20.8M	22.7M	18.4M	15.6M
Depreciation And Amortization	55.9M	169.7M	56.5M	56.6M	56.6M	56.5M	41.7M	35.5M
Ebitda	90.5M	303.6M	121.7M	94.1M	80.5M	96.4M	75.7M	80.2M
Ebitdaratio	0.468	1.478	0.581	0.501	0.453	0.53	0.475	0.552
Operating Income Ratio	0.165	0.288	0.304	0.187	0.122	0.209	0.219	0.327
Income Before Tax	18.7M	29.0M	43.4M	17.0M	3.1M	17.3M	15.6M	29.1M
Income Before Tax Ratio	0.097	0.141	0.207	0.091	0.018	0.095	0.098	0.20
Income Tax Expense	4.2M	12.1M	11.9M	5.0M	705K	4.7M	6.2M	9.5M
Net Income Ratio	0.075	0.083	0.15	0.064	0.014	0.069	0.059	0.135
Epsdiluted	0.40	0.46	0.84	0.34	0.074	0.35	0.27	0.52
Weighted Average Shs Out	32.1M	31.7M	31.6M	31.8M	31.8M	32.1M	32.3M	32.4M
Weighted Average Shs Out Dil	40.1M	39.7M	39.4M	39.1M	32.8M	40.1M	40.2M	40.4M